The Prevalence of Wound Complications after Cardiac Surgery
https://doi.org/10.31631/2073-3046-2020-19-6-101-107
Abstract
Relevance. Infectious complications arising in the postoperative period (nosocomial infections) have an adverse effect on the results of high-tech interventions in a cardiac surgery clinic, worsening clinical results and being a significant article of medical expenses. Aims. To analyze modern literature data on the prevalence of nosocomial infections after high-tech cardiac surgery to identify factors that affect its variability. Conclusions. The prevalence of hospital Infectious complications after cardiac surgery remains high, ranging, according to various sources, from 0.9% to 35%. The deep form, accompanied by a significant mortality rate, is more common in the range from 0.4% to 5%, the incidence of superficial forms is much more variable, leaving from 1.5% to 30%. A prerequisite for controlling infection in a cardiac surgery hospital is thorough and adequate registration of such complications. Conducting a dynamic comparison of the prevalence of nosocomial infections in the process of epidemiological control requires the consistent use of unchanged methods of statistical analysis, constant criteria for determining a standard case and the use of up-to-date classifications. An important step in the study of the prevalence of nosocomial infections is to provide the obtained information to practicing physicians in order to maintain a high level of awareness of the effectiveness of treatment and prevention.
About the Authors
A. V. Stepin
Ural Institute of Cardiology
Russian Federation
Russian Federation
Stepin Artem V. - Cand. Sci. (Med.), Head of Cardiac Surgery Department in Ural Institute of Cardiology.
620142 Ekaterinburg, 8th March 78a.
Tel. +7(343) 2951376
S. A. Matveev
Ural Institute of Cardiology
Russian Federation
Russian Federation
Matveev Sergey A. - cardiac surgeon in Ural Institute of Cardiology.
620142 Ekaterinburg, 8th March 78a.
D. A. Mamontov
Ural Institute of Cardiology
Russian Federation
Russian Federation
Mamontov Dmitry A. - cardiac surgeon in Ural Institute of Cardiology.
620142 Ekaterinburg, 8th March 78a.
References
1. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004 Jun 15;38(12):1706-15. doi: 10.1086/421095.
2. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clinical Infectious Diseases. 2006;4:322-330.
3. Bokeriya LA, Beloborodova NV. Infection in cardiac surgery. NCSSX im. AN Bakylev RAMN., Moscow 2007;582 (In Russ).
4. Bokeriya LA, Gudkova RG. Cardio-vascular surgery-2016. Bolezni i vrogdennie anomalii sistemi krovoobrascheniya. Moscow: NCSSX im. AN Bakylev. 2017:196 (In Russ).
5. Kazachek YV, Pomeshkina SA, Barbarash OL. Profilaktika infektsionnykh oslozhneniy v kardiokhirurgii. Kompleksnyye problemy serdechno-sosudistykh zabolevaniy. 2014;4:62-69 (In Russ).
6. Custovic A, Smajlovic J, Hadzic S, et al. Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit. Materia Socio Medica. 2014;26(1):7-11.
7. Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis after cardiac surgery. Annals of Thoracic Surgery. 2004;77:676-683.
8. Ennker IC, Pietrowski D, Vohringer L, et al. Surgical debridement, vacuum therapy and pectoralis plasty in poststernotomy mediastinitis. Journal of Plastic, Reconstructive and Aesthetic Surgery. 2009;62:1479-1483.
9. Graf K, Ott E, Vonberg RP, et al. Economic aspects of deep sternal wound infections. European Journal of Cardiothoracic Surgery. 2010;37:893-896.
10. Ridderstolpe L, Gilla H, Granfeldtb H, et al. Superficial and deep sternal wound complications: incidence, risk factors and mortality. European Journal of Cardio-thoracic Surgery. 2001;20:1168-1175.
11. Lu JC, Grayson AD, Jha P, et al. Risk factors for sternal wound infection and mid-term survival following coronary artery bypass surgery. European Journal of Cardiothoracic Surgery. 2003;23:943-949.
12. Salehi Omran A, Karimi A, Ahmadi SH, et al. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infectious Disease. 2007;7:112-117.
13. Wang FD, Chang CH. Risk factors of deep sternal wound infections in coronary artery bypass graft surgery. Journal of Cardiovascular Surgery. 2000;41:709-713.
14. Асланов Б. И., Зуева Л. П., Колосовская Е. Н. и др. Принципы организации периоперационной антибиотикопрофилактики в учреждениях здравоохранения. Федеральные клинические рекомендации. М. 2014. Доступно на: http://nasci.ru/?id=3370 ссылка активна на 28 октября 2020.
15. Anonymous. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004. The American Journal of Infection Control. 2004;32(2):470-485.
16. Robicsek F, Fokin A, Cook J, et al. Sternal instability after midline sternotomy.// Journal of Thoracic and Cardiovascular Surgery. 2000;48:1-8.
17. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Annals of Thoracic Surgery. 1996;61:1030-1036.
18. Ulicny JrKS, Hiratzka LF. The risk factors of median sternotomy infection: a current review. Journal of Thoracic Cardiac Surgery 1991;6:338-351.
19. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. The American Journal of Infection Control. 2004;32:470-485.
20. Pasquali SK, Sun JL, d'Almada P, et al. Center variation in hospital costs for patients undergoing congenital heart surgery. Circulation: Cardiovascular Quality Outcomes. 2011;4:306-312.
21. Shih T, Zhang M, Kommareddi M, et al. Center-Level Variation in Infection Rates After Coronary Artery Bypass Grafting. Circulation: Cardiovascular Quality and Outcomes. 2014;7(2):567-573.
22. Loop FD, Lytle BW, Cosgrove DM, et al. Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Annals of Thoracic Surgery. 1990;49:179-187.
23. Mazzeffi M, Zivot J, Buchman T, et al. In-hospital mortality after cardiac surgery: patient characteristics, timing, and association with postoperative length of intensive care unit and hospital stay. Annals of Thoracic Surgery. 2014; (97)4:1220-1225.
24. Gorbunov VA, Dgordgikiya RK, Vagizov II. Prevention and treatment of wound infection in cardiac surgery patients [Abstract]. In: XXI All-Russian Congress of Cardiovascular Surgeons. Moscow: Izdatelstvo FGBU «NMICSSX im. AN Bakylev. 2015. P. 321 (In Russ).
25. Bryan CS, Yarbrough WM. Preventing deep wound infection after coronary artery bypass grafting: a review. Texas Heart Institutional Journal. 2013;40:125-139.
26. Kanafani ZA, Arduino JM, Muhlbaier LH, et al. Incidence of and preoperative risk factors for Staphylococcus aureus bacteremia and chest wound infection after cardiac surgery. Infection Control and Hospital Epidemiology. 2009;30:242-248.
27. Karra R, McDermott L, Connelly S, et al. Risk factors for 1-year mortality after postoperative mediastinitis. Journal of Thoracic and Cardiovascular Surgery. 2006;132:537-543.
28. Filsoufi F., Castillo J.G., Rahmanian P.B., et al. Epidemiology of deep sternal wound infection in cardiac surgery // Journal of Cardiothoracic and Vascular Anesthesia. 2009;23:488-494.
29. Gelijns AC, Moskowitz AJ, Acker MA, et al. Management practices and major infections after cardiac surgery // J Am Coll Cardiol. 2014;64(4):372-81.
30. Taylor GJ, M ikell FL, Moses HW. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications.The A meri-can Journal of Cardiology. 1990;65:309-313.
31. Shahian DM, O'Brien SM, Filardo G, et al.The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Annals of Thoracic Surgery. 2009;88(1):2-22.
32. Shahian DM, Zhang M, Kommareddi M, et al. Center-Level Variation in Infection Rates After Coronary Artery Bypass Grafting. Circulation: Cardiovascular Quality and Outcomes. 2014; 7. (2):567-573.
33. Shahian DM, Kim SH, Kim DJ, et all. Sternal healing after coronary artery bypass grafting using bilateral internal thoracic arteries: assessment by computed tomography scan. Korean Journal of Thoracic and Cardiovascular Surgery. 2015;48:33-39.
34. Alwaqfi NR, Khader YS, Ibrahim KS, et al. Coronary artery bypass grafting: 30-day operative morbidity analysis in 1046 patients. Journal of Clinical Medicine Research. 2012;4(3):267-273.
35. Berrios-Torres SI, Mu Y, Edwards JR, et al. Improved risk adjustment in public reporting: coronary artery bypass graft surgical site infections. Infection Control & Hospital Epidemiology. 2012;33:463-469.
36. Chia-Hui Shih B, Chung S, Kim H, et al. Outcomes and patency of complex configurations of composite grafts using bilateral internal thoracic arteries.Korean Journal of Thoracic and Cardiovascular Surgery. 2020;53(2):64-72.
37. Chung S, Wook SK, Dong SJ, et al. Outcomes of off-pump coronary bypass grafting with the bilateral internal thoracic artery for left ventricular dysfunction. Journal of Korean Medical Science. 2014;29:69-75.
38. Cristofolini M, Worlitzsch D, Wienke A, et al. Surgical site infections after coronary artery bypass graft surgery: incidence, perioperative hospital stay, readmissions, and revision surgeries. Infection. 2012;40:96-404.
39. El Bardissi AW, Aranki SF, Sheng S, et al. Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. Journal of Thoracic and Cardiovascular Surgery. 2012;143:273-28.
40. Fowler VG Jr, Kaye KS, Simel DL, et al. Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. Circulation. 2003;108:73-78.
41. Gummert JF, Barten MJ, Hans C, et al. Mediastinitis and cardiac surgery: an updated risk factor analysis in 10,373 consecutive adult patients. The Thoracic and Cardiovascular Surgeon. 2002;50:87-91.
42. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation. American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:652-735.
43. Kubota H, Miyata H, Motomura N, et al. Deep sternal wound infection after cardiac surgery. Journal of Cardiothoracic Surgery. 2013;8:132-138.
44. Milano CA, Kesler K, Archibald N, et al. Mediastinitis after coronary artery bypass graft surgery: risk factors and long-term survival. Circulation. 1995;92:2245 -2251.
45. Tom TS, Kruse MW, Reichman RT. Update: Methicillin-resistant Staphylococcus aureus screening and decolonization in cardiac surgery. Annals of Thoracic Surgery. 2009;88:695-702.
46. Garey KW, Lai D, Dao-Tran TK, et al. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrobial Agents and Chemotherapy. 2008;52(2):446-451.
47. Garey KW, Dao T, Chen H, et al. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. Journal of Antimicrobial Chemotherapy. 2006;5:645-650.
48. Chernyavskii AM, Tarkova AR, Ruzmatov TM et al. Infections in cardiac surgery. Hirurgiya. Jurnal im NI Pirogova. 2016;5:64-68 (In Russ).
49. Gabrielyan NI, Savostyanova OA, Gorskaya EM, et al. The epidemiological and microbiological characteristics of the postoperative period in older patients in cardiac surgery. Epidemiology and Vaccinal Prevention. 2015;14(5):51-55 (In Russ.). DOI: 10.31631/2073-3046-2015-14-5-51-55.
50. Tsoy ER, Zueva LP, Mikaelyan SM. Surgical site infection in cardiac surgery, open- heart surgery infection. Epidemiology and Vaccinal Prevention. 2020;19(3);52-56. (In Russ) DOI: 10.31631/2073-3046-2020-19-3-52-56.
51. Aliev NM, Andrievskih SI, Davidov IV. Multivariate analysis of the causes of postoperative wound complications [Abstract]. In: XXI All-Russian Congress of Cardiovascular Surgeons. Moscow: Izdatelstvo FGBU «NMICSSX im. AN Bakylev; 2016. P. 321. (In Russ)
52. Brown JR., Edwards FH, O'Connor GT, et al. The diabetic disadvantage: historical outcomes measures in diabetic patients undergoing cardiac surgery - the pre-intravenous insulin era // Seminars in Thoracic and Cardiovascular Surgery. 2006;8:281-288.
53. Speir AM, Kasirajan V, Barnett SD, et al. Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia. Annals of Thoracic Surgery. 2009;88:40-45.
54. Jonkers D, Elenbaas T, Terporten P, et al. Prevalence of 90-days postoperative wound infections after cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2003;23:97-102.
55. Shin YC, Kim SH, Kim DJ, et al. Sternal healing after coronary artery bypass grafting using bilateral internal thoracic arteries: assessment by computed tomography scan. Korean Journal of Thoracic and Cardiovascular Surgery. 2015;48:33-39.
Review
For citations:
Stepin A.V., Matveev S.A., Mamontov D.A. The Prevalence of Wound Complications after Cardiac Surgery. Epidemiology and Vaccinal Prevention. 2020;19(6):101-107. (In Russ.) https://doi.org/10.31631/2073-3046-2020-19-6-101-107
Views:
624
Email this article 